Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

38
Neuroradiology- Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD

Transcript of Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

Page 1: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

Neuroradiology-Neuropathology ConferenceMay, 2011Michael Solle, MDTom Bouldin, MD

Page 2: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

History 31 y/o male with 9 days headaches and

nausea, and intermittent confusion.

Page 3: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.
Page 4: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.
Page 5: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

ADC rCBV SWI

Page 6: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.
Page 7: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

Pathology▪ Sections show proliferation of atypical astrocytes.

Mitotic figures are identified. Microvascular proliferation is present. Foci of necrosis are also present. Histologic changes are consistent with glioblastoma.

▪ Glioblastoma, WHO grade IV

Page 8: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

CNS tumor classification (NCI webpage):

▪ WHO grade I includes lesions with low proliferative potential, a frequently discrete nature, and the possibility of cure following surgical resection alone.

▪ WHO grade II includes lesions that are generally infiltrating and low in mitotic activity but recur. Some tumor types tend to progress to higher grades of malignancy.

▪ WHO grade III includes lesions with histologic evidence of malignancy, generally in the form of mitotic activity, clearly expressed infiltrative capabilities, and anaplasia.

WHO grade IV includes lesions that are mitotically active, necrosis-prone, and generally associated with a rapid preoperative and postoperative evolution of disease.

Page 9: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

History Patient was initially diagnosed with a

posterior fossa mass presenting with headaches and vision disturbances in 6/2007.

Page 10: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.
Page 11: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.
Page 12: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

Pathology Juvenile Pilocytic Astrocytoms, WHO

grade I. Sections of posterior fossa mass show

moderately cellular glial proliferation with modest atypia and scattered Rosenthal fibers and eosinophilic granular bodies. Focally, there are microcytic changes within the cellular proliferation. No mitoses or necrosis are identified. ▪ Tumor cells stain positively for GFAP and negatively

for synaptophysin.

Page 13: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

History 3 y-o male complaining of intermittent

severe headache, was noted to have some gait ataxia by his mother.

Page 14: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.
Page 15: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.
Page 16: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.
Page 17: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

Lumbar puncture-Malignant cells present, consistent with medulloblastoma.

Page 18: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

Pathology Intraoperative:

▪ Small round cell tumor consistent with medulloblastoma. Final:

▪ Sections show a densely cellular neoplasm with small to medium sized nuclei. Some cells show nucleoli. There are mitotic figures and apoptosis. Also present are anaplastic features, including cell wrapping.

Immunohistochemical stains for synaptophysin, chromogranin, EMA, and GFAP are performed. The tumor cells are diffusely positive for synaptophysin. There are a few cells staining faintly for chromogranin. There are areas of strong staining for GFAP. There is only slight, focal, nonspecific staining for EMA. Controls immunostain appropriately. The immunohistochemical findings are consistent with medulloblastoma.

▪ Areas of this tumor show marked atypia, worrisome for anaplastic features. A stain for INI-1 was positive in tumor cells, ruling out ATRT.

Page 19: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

Anaplastic medulloblastoma

Page 20: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

Medulloblastoma

“Classic” medulloblastoma

Desmoplastic/nodular medulloblastoma

Medulloblastoma with extensive nodularity

Large cell medulloblastoma and anaplastic medulloblastoma(large cell/anaplastic medulloblastoma)

Pathological Subtypes of Medulloblasoma

Page 21: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

History … consultation for evaluation of a

suprasellar mass… 41-year-old right-handed woman who has noted the onset of headaches for several years

… some confusion and memory loss … progressive loss of vision, particularly

in the periphery of her right eye since 8/2010.

Page 22: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.
Page 23: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.
Page 24: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.
Page 25: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.
Page 26: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

Operative Findings: 1) Normal pituitary gland 2) diffusely infiltrative infundibular mass with

subchiasmatic compression 3) gross total resection 4) preservation of right superior hypophyseal

artery and perforators 5) visualization of third ventricle, basilar

artery, posterior cerebral arteries, posterior communicating arteries, anterior communicating arteries, A2 vessels, A1 vessels, bilaterally.

Page 27: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

Pathology Intraoperative:

▪ Granular cell tumor of the infundibulum Final:

▪ Sections show a patternless proliferation of large cells with oval nuclei and large amounts of pink cytoplasm. Cytoplasm has a fine granularity. Modest nuclear pleomorphism.Sections stained with PAS-D, S-100, GFAP, synaptophysin, and CD68. Tumor cells show PAS-positive granules in cytoplasm. Tumor cells show positive immunostaining for S100 and GFAP. Tumor cells do not stain for synaptophysin. Numerous CD68-positive cells, consistent with macrophages, are scattered throughout the tumor.

Page 28: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

PASH&E

Page 29: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

• Rare tumor arising in the sella turcica or suprasellar space.

• Arises from pituicytes, which are specialized astrocytes found in the posterior pituitary (neurohypophysis).

• Pituicytes give rise to granular cell tumors and pituicytomas, which are phenotypic variants.

Granular Cell Tumor of the Infundibulum

Page 30: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

History 68 y-o female with multiple past cancers

(lymphoma, breast, thyroid, melanoma) presenting with recently diagnosed lung and brain masses. Patient became acutely aphasic and was taken to the ED out of concern for a possible stroke.

Page 31: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.
Page 32: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.
Page 33: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.
Page 34: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

Pathology; Autopsy; Gross Description: Large numbers of black, well

circumscribed tumors, consistent with metastases, in all lobes of the cerebrum. Metastases are often, but not always, located at the gray/white junctions. Tumors vary from 2 mm to 2 cm in diameter.…. The deep gray matter nuclei also contain metastases.

Page 35: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

Pathology: Light Microscopy. There is considerable involvement of

leptomeninges by the metastatic melanoma. Tumor cells show marked pleomorphism. Some of neoplastic cells contain brown pigment. ▪ Immunohistochemical stains for S-100, Mart-1, and

GFAP done on sections from brain. Many neoplastic cells show positive staining for S-100. Scattered neoplastic cells show positive staining for MART-1. The positive staining of some cells for S-100 and MART-1 and presence of brown pigment are consistent with malignant melanoma.

Page 36: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.
Page 37: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.
Page 38: Neuroradiology-Neuropathology Conference May, 2011 Michael Solle, MD Tom Bouldin, MD.

40-60% of patients with melanoma have brain metastasis.

Melanoma cells are closely related to CNS cells due to their embryonic origin and neural crest cells, and they share common antigens such as MAG-1 and MAG-2.

After melanoma is detected in the brain, median survival is 3 months. 

Source: eMedicine, brain metastases article.

▪ http://emedicine.medscape.com/article/1157902-overview#a0199